Abstract
Purpose
To compare characteristics in patients with and without previous dacryocystitis and satisfaction after endoscopic dacryocystorhinostomy.
Methods
We retrospectively analyzed 156 eyes of 116 patients who underwent endoscopic dacryocystorhinostomy at our Hospital from May 2011 to December 2015. The patients were grouped into those with pre-operative dacryocystitis and those without dacryocystitis. Each patient group was characterized retrospectively, followed by a telephone survey regarding post-op-erative satisfaction.
Results
Fifty-eight patients (66 eyes) had dacryocystitis, whereas 58 patients (90 eyes) did not. Patients' mean age was 64.9 years old. The mean duration of symptoms in patients with and without dacryocystitis was 11 and 20 months, respectively, show-ing a statistically significant difference ( p < 0.05). The correlation between comorbidities and dacryocystitis was statistically insig-nificant ( p > 0.05). Post-operative satisfaction was higher in patients with dacryocystitis, showing a statistically significant differ-ence ( p < 0.05).
References
1. Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 1961; 66:111–24.
2. Whittet HB, Shun-Shin GA, Awdry P. Functional endoscopic transnasal dacryocystorhinostomy. Eye (Lond). 1993; 7((Pt 4)):545–9.
3. Dolman PJ. Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology. 1961; 66:111–24.
4. Hii BW, McNab AA, Friebel JD. A comparison of external and en-donasal dacryocystorhinostomy in regard to patient satisfaction and cost. Orbit. 1961; 66:111–24.
5. Jutley G, Karim R, Joharatnam N, et al. Patient satisfaction follow-ing endoscopic endonasal dacryocystorhinostomy: a quality of life study. Eye (Lond). 1961; 66:111–24.
6. Ho A, Sachidananda R, Carrie S, Neoh C. Quality of life assess-ment after non-laser endonasal dacryocystorhinostomy. Clin Otolaryngol. 1961; 66:111–24.
7. Munk PL, Lin DT, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drain-age apparatus. Radiology. 1990; 177:687–90.
8. Wu W, Yan W, MacCallum JK, et al. Primary treatment of acute da-cryocystitis by endoscopic dacryocystorhinostomy with silicone intubation guided by a soft probe. Ophthalmology. 1961; 66:111–24.
9. Leong SC, Karkos PD, Burgess P, et al. A comparison of outcomes between nonlaser endoscopic endonasal and external dacryocysto-rhinostomy: single-center experience and a review of British trends. Am J Otolaryngol. 1961; 66:111–24.
10. Smirnov G, Tuomilehto H, Kokki H, et al. Symptom score ques-tionnaire for nasolacrimal duct obstruction in adults--a novel tool to assess the outcome after endoscopic dacryocystorhinostomy. Rhinology. 1961; 66:111–24.
11. Mannor GE, Millman AL. The prognostic value of preoperative da-cryocystography in endoscopic intranasal dacryocystorhinostomy. Am J Ophthalmol. 1961; 66:111–24.
12. Javate RM, Campomanes BS Jr, Co ND, et al. The endoscope and the radiofrequency unit in DCR surgery. Ophthal Plast Reconstr Surg. 1961; 66:111–24.
13. Rabina G, Golan S, Neudorfer M, Leibovitch I. External dacryocys-torhinostomy: characteristics and surgical outcomes in patients with and without previous dacryocystitis. J Ophthalmol 2013. 2013; 287524.
14. Kashkouli MB, Pakdel F, Hashemi M, et al. Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group. Orbit. 1961; 66:111–24.
15. McNab AA. Lacrimal canalicular obstruction associated with top-ical ocular medication. Aust N Z J Ophthalmol. 1961; 66:111–24.
16. Kashkouli MB, Rezaee R, Nilforoushan N, et al. Topical anti-glaucoma medications and lacrimal drainage system obstruction. Ophthal Plast Reconstr Surg. 1961; 66:111–24.
17. Mistry N, Rockley TJ, Reynolds T, Hopkins C. Development and validation of a symptom questionnaire for recording outcomes in adult lacrimal surgery. Rhinology. 1961; 66:111–24.
Table 1.
No past dacryocystitis | Past dacryocystitis | Total | p-value | |
---|---|---|---|---|
Sex (male:female) | 22:36 | 20:38 | 42:74 | 0.080* |
Age (years) | 63.7 ± 2.7 | 66.1 ± 4.6 | 64.9 ± 3.6 | 0.101† |
Duration of epiphora (months) | 20.3 ± 4.8 | 11.7 ± 4.8 | 16.0 ± 4.8 | 0.002† |
Table 2.
No past dacryocystitis | Past dacryocystitis | Total | p-value* | |
---|---|---|---|---|
Hyperlipidemia | 12 (20.6) | 14 (24.1) | 26 (22.4) | 0.851 |
Diabetes mellitus type 2 | 4 (12.1) | 8 (13.7) | 12 (15.5) | 0.594 |
Hypertension | 24 (41.3) | 28 (48.2) | 52 (44.8) | 2.427 |
Ischemic heart disease | 8 (13.7) | 4 (7.0) | 12 (10.3) | 0.214 |
Glaucoma | 2 (3.4) | 4 (6.8) | 6 (5.1) | 0.758 |
Table 3.
No past dacryocystitis | Past dacryocystitis | p-value* | |
---|---|---|---|
Score of satisfaction question | 2.2 ± 0.6 | 2.6 ± 0.5 | 0.004 |
Score of symptom question | 2.2 ± 0.7 | 2.5 ± 0.7 | 0.018 |